NCT00000224View on ClinicalTrials.gov

Alternate-Day Buprenorphine. Phase V - 6

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

February 28, 1993

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors
collaborator

University of Vermont

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000224 - Alternate-Day Buprenorphine. Phase V - 6 | Biotech Hunter | Biotech Hunter